4//SEC Filing
Zoghbi Huda Y 4
Accession 0001968202-23-000037
CIK 0000872589other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:06 PM ET
Size
8.2 KB
Accession
0001968202-23-000037
Insider Transaction Report
Form 4
Zoghbi Huda Y
Director
Transactions
- Exercise/Conversion
Common Stock
2023-10-13$391.92/sh+1,000$391,920→ 2,247 total - Sale
Common Stock
2023-10-13$850.00/sh−1,000$850,000→ 1,247 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-10-13−1,000→ 1,117 totalExercise: $391.92Exp: 2026-09-09→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023.
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001681643
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:06 PM ET
- Size
- 8.2 KB